Contemporary trends in utilization of metastasectomy in the era of targeted and immunotherapies
Between 2016 and 2021, utilization of metastasectomy increased significantly for melanoma and breast cancer. The role of metastasectomy will likely continue to develop as new treatment protocols improve survival profiles for patients with metastatic disease.
Authors
- Michael J. Kallan
- Douglas L. Fraker (ORCID: https://orcid.org/0000-0002-6391-5852)
- Wajid Amjad
- Heather Wachtel (ORCID: https://orcid.org/0000-0003-3786-3638)
- Giorgos C. Karakousis (ORCID: https://orcid.org/0000-0002-9321-2795)
- Edmund K. Bartlett (ORCID: https://orcid.org/0000-0002-0923-153X)
- Jesse E. Passman (ORCID: https://orcid.org/0000-0002-6599-0397)
- Jacqueline M. Soegaard Ballester (ORCID: https://orcid.org/0000-0002-5826-8275)
- Gabriella N. Tortorello (ORCID: https://orcid.org/0000-0002-1836-6612)
- Jeffrey L. Roberson (ORCID: https://orcid.org/0000-0002-0168-8578)
- Sara P. Ginzberg (ORCID: https://orcid.org/0000-0003-1657-0617)
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- Hospital of the University of Pennsylvania (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Cancer
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1002/cncr.35664
- Citations
- 2
- Primary Topic
- Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Memorial Sloan-Kettering Cancer Center
- National Institutes of Health
- National Cancer Institute